These data provide strong evidence that the B2 bradykinin receptor enhances the progression of atherosclerotic plaque formation in the aorta of 8-month-old ApoE–/– mice as an experimental model of atherosclerosis. Here, BDKRB2 is linked to atherosclerosis.